Pfizer to Create 400 R&D Jobs - Sept. 2, 2011

Having trouble viewing this email? View in Browser.

Friday, September 02, 2011  |   |   |   |  CHI's 11 Annual PepTalk: The Protein Science WeeK January 9-13, 2012 | Hotel Del Coronado | San Diego, CA www.chi-peptalk.com PepTalk 2012 continues the tradition of strong scientific programming centered around protein-based therapeutics. The four distinct protein pipelines focused on formulation, purification, biotherapeutics and expression range from applying protein discovery research, to developing downstream protein products that ultimately lead to clinical applications. Create your own agenda by moving between the tracks and choosing the sessions that best fit your research and networking needs. Please click here for more information.   •  Pfizer Inc. (PFE) to Create 400 R&D Jobs More... •  AstraZeneca PLC (AZN)'s Crestor Fails to Beat Pfizer Inc. (PFE)'s Lipitor More... •  FDA Warns of Severe Allergy Risk with Merck & Co., Inc. (MRK) Antipsychotic More... •  FDA: Novartis Corporation (NVS)'s Osteoporosis Drug Reclast Raises Kidney Failure Risk More... •  EU Grants Approval for Expanded Use of Roche (RHHBY)'s Tarceva More... •  Genzyme Corporation (GENZ) Returns Drug Rights to PTC Therapeutics, Inc. More... •  Eli Lilly and Company (LLY) May Partner With Turkish Generic Maker More... •  Repligen Corporation (RGEN) Seeks Approval for Imaging Product While Pursuing Rare-Disease Drugs and Manufacturing Platform More... More Top News 2011 Bioscience Vision Summit Thursday, September 8, 2011 Madison Marriott West, Middleton WI Join the nearly 400 people who have already registered, for provocative and informed discussions on advancing the industry. From drug development and medical devices, to creating the bioenergy supply chain , to bridging the divide between organic farming and genetic engineering, this year's event promises to bring together leaders who are creating the products and jobs of the future. Hear from Ernst & Young the results of their 2011 Global Biotechnology Report, participate in sessions on bridge financing, corporate governance and incorporating lean principles into your own business, and discuss challenges and solutions unique to the industry. New this year - 16 career sessions, and 5 lab application seminars for scientists and students interested in advancing their careers. •  Novartis Corporation (NVS)' Generics Firm's Edge More... •  Signs of Aging May Be Linked to Undetected Blocked Brain Blood Vessels, Rush University Medical Center Study More... •  Why Some Body Fat is More Dangerous, University of California, Davis (UCD) Study More... •  Women Who Marry as Children at Greater Risk for Mental Illness, Centre for Addiction and Mental Health Study More... •  Gut Bacteria Picky About What We Eat, University of Pennsylvania Study More... •  Mouse Study Could Give New Clues to Fighting Baldness, Yale University Study More... •  Vitamin D Levels Tied To Colon Cancer Risk, Sixth People's Hospital and Shanghai Jiao Tong University Study More... •  9/11 Firefighters Have Higher Cancer Risk, National Institute for Occupational Safety and Health Study More...   More Featured News IBC's BioProcess International Conference & Exhibition October 31 - November 4, 2011 - Long Beach, California Event Website Download the 2011 BioProcess International brochure and see why this is YOUR must attend event for 2011. Download your PDF here. You will see the 2011 program, features a stellar line up keynote presentations including, the US FDA, EMA, Pfizer, Merck and more. Plus, there are over 50 presentations with new, previously unpublished data, and new topic coverage areas including antibody drug conjugates, viral clearance and managing global manufacturing facilities and partners. Register by September 9 and you will save $200 off the standard conference rates with priority code B11171BSEODS. Exhibit hall & keynote passes are now available. Mention priority code B11171BSEODS and the fee will be waived. All passes subject to approval. Register here today or call 800-390-4078. Advancing Molecular Diagnostics to Personalize Cancer Therapy • Identify key innovations in molecular diagnostics for oncology that may compete with those in development at your company. • Understand the regulatory challenges facing the developers of molecular diagnostics for cancer. • Understand the challenges that surround successfully commercializing a combined drug-diagnostic product and learn how to overcome them. • Discover and analyze the key technology platforms being used in the development of novel molecular diagnostics. Click Here for More Information Nature Methods Nature Methods provides techniques for life scientists and chemists. It is a print and online publication dedicated to publishing novel methods together with significant advances to tried and tested techniques allowing researchers to perform faster, better and more efficient experimental research. Request Now! • Pharm Country (Rochester, New York) Vaccinex, Inc. Director, Clinical Development Responsible for providing clinical direction, clinical operations management, and clinical safety review for the companys ongoing clinical trials in oncology and multiple sclerosis, as well as providing advanced leadership in the clinical aspects of drug development and protocol design for these indications. • Bio NC (Research Triangle Park, North Carolina) Advanced Liquid Logic Scientist/Enzymologist Responsible for planning, designing and running experiments for the purpose of assay development and translation for the purpose sample preparation development and translation. The primary focus is to assist with the transition of research results to useful and manufacturable products, developing core Biochemistry competencies and translating to the digital microfluidic platform. • Genetown (Cambridge, Massachusetts) Acceleron Pharma Associate Director/Director Quality Assurance Manage the systems and procedures that ensure compliance with ICH guidelines and FDA/EMEA applicable regulations (cGLP, cGMP, cGCP). Ensure that company procedures are consistent with clinical and development activities. • BioCapital (Frederick, Maryland) SAIC-Frederick, Inc. Research Associate III Responsible for contacting and interacting with equipment representatives; negotiating costs for equipment and determining the best options for purchases; establishing space for microscopy set-up; initializing stock; arranging laboratory space; training new post-docs in cell biology and microscopy techniques; maintaining tissue culture cell lines; participating in biochemical/mass spec studies aimed at characterizing centrosome components; preparing manuscripts and presenting results at meetings. • BioForest (Eugene, Oregon) Life Technologies Scientist III, Production Responsible for technical troubleshooting of products and manufacturing processes, for the development and transfer of new products, and for initiating process improvements in organic chemistry production at the Eugene site. Get Noticed! Add your resume to the BioSpace Career Center! See more than 5,000 job postings in the BioSpace Career Center! Biotech Beach Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Southern California region. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Biotech Beach Career Fair, San Diego, CA September 22, 2011 • BioMidwest Career Fair, Chicago, IL October 4, 2011 • Pharm Country Career Fair, Bridgewater, NJ October 5, 2011 • Biotech Bay Career Fair, Burlingame, CA October 11, 2011 • Bio NC Career Fair, Durham, NC October 20, 2011 • BioCapital Beach Career Fair, Bethesda, MD November 1, 2011 • Genetown Career Fair, Cambridge, MA November 7, 2011 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services Dynavax Technologies Corporation 2929 Seventh Street, Suite 100 Berkeley, California 94710 U.S.A. Phone: 510-848-5100 Fax: 510-848-1379 Dynavax Technologies Corporation is a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. Our clinical-stage product candidates include: Phase 3 HEPLISAV™ Hepatitis B Vaccine, Phase 1 Universal Flu Vaccine, Phase 1 Hepatitis C Therapy and Phase 1 Hepatitis B Therapy. More Company Profiles FREE Subscription to CAP Today CAP Today brings monthly business and medical news in the clinical laboratory. CAP Today, the College of American Pathologists' monthly news magazine, is the laboratory community's primary source of information on business and medical news in the clinical laboratory. Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship BioSpace Inc. 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 BioSpace Inc. 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the BioSpace News Beat Team. Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Suvarna Sheth, Maysa Darwish, Tammy Liu BioSpace.com - Life. Science. Community. • BioSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2011 BioSpace http://www.biospace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.